Coronavirus pandemic: daily updated research and data.
Read more

Our data on COVID-19 vaccinations is updated each morning (London time), with the most recent official numbers up to the previous day.

In our Data Explorer you can see all of our data on COVID-19 vaccinations (doses administered, people with at least 1 dose, and people fully vaccinated).

Open the Data Explorer in a new tab.

Select a group of countries at once: all European countries, 30 largest countries; EU; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

How many COVID-19 vaccine doses are administered daily?

Daily number of COVID-19 vaccinations administered per 100 people

The following chart shows the daily number of COVID-19 vaccination doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered

How many COVID-19 vaccination doses have been administered?

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime as several available COVID vaccines require multiple doses.

Total number of COVID-19 vaccinations administered

The following chart shows the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

What share of the population has received at least one dose of the COVID-19 vaccine?

The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine. This may not equal the share that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of the COVID-19 vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has been fully vaccinated against COVID-19?

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Total number of people who have been fully vaccinated against COVID-19

The following chart shows the total number of people that have been fully vaccinated against COVID-19. This represents the number that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer.

This is only available for a select number of countries which report the necessary data.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccinations

The Imperial College London YouGov Covid-19 Behaviour Tracker Data Hub gathers global insights on people’s behaviors in response to COVID-19. This survey covers public behaviors and attitudes ranging from mask-wearing to self-isolation, social distancing, symptoms and testing.

The following chart shows monthly data on public willingness to receive the COVID-19 vaccine.

Data represents the share of respondents that agree with the following statement: “If a COVID-19 vaccine were made available to me this week, I would definitely get it.” Respondents were presented with a 1 to 5 scale, ranging from “Strongly agree” (1) to “Strongly disagree” (5). We consider responses of 1 or 2 to be in agreement with the statement.

Vaccine development: vaccines approved for use and in clinical trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries. 

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Source information country by country

You can download the full dataset alongside the detailed source descriptions on GitHub.

Note that other countries may have also started vaccination campaigns—we’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources.

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. The exact values can be viewed in our GitHub repository.

Vaccination against COVID-19 has now started in 170 locations, covering 92% of the world population.

LocationSourceLast observation dateVaccines
AfghanistanGovernment of AfghanistanApr. 7, 2021Oxford/AstraZeneca
AlbaniaMinistry of HealthApr. 10, 2021Pfizer/BioNTech, Sinovac
AlgeriaMinistry of HealthFeb. 19, 2021Sputnik V
AndorraGovernment of AndorraApr. 4, 2021Pfizer/BioNTech
AngolaMinistry of HealthApr. 6, 2021Oxford/AstraZeneca
AnguillaMinistry of HealthMar. 19, 2021Oxford/AstraZeneca
Antigua and BarbudaMinistry of HealthMar. 25, 2021Oxford/AstraZeneca
ArgentinaMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
ArmeniaMinistry of HealthMar. 31, 2021Sputnik V
AustraliaGovernment of Australia via covidlive.com.auApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanApr. 10, 2021Sinovac
BahamasGovernment of the BahamasMar. 18, 2021Oxford/AstraZeneca
BahrainMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesApr. 10, 2021Oxford/AstraZeneca
BarbadosMinistry of HealthApr. 9, 2021Oxford/AstraZeneca
BelarusMinistry of HealthMar. 26, 2021Sputnik V
BelgiumSciensanoApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeMinistry of HealthApr. 9, 2021Oxford/AstraZeneca
BermudaGovernment of BermudaApr. 4, 2021Pfizer/BioNTech
BhutanMinistry of HealthApr. 10, 2021Oxford/AstraZeneca
BoliviaMinistry of HealthApr. 9, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
BotswanaMinistry of Health and WellnessApr. 2, 2021Oxford/AstraZeneca
BrazilMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Sinovac
BruneiMinistry of HealthApr. 3, 2021Oxford/AstraZeneca
BulgariaMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CambodiaMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CanadaOfficial data from provinces via covid19tracker.caApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeGovernment of Cape VerdeMar. 24, 2021Oxford/AstraZeneca
Cayman IslandsCayman Islands GovernmentApr. 9, 2021Pfizer/BioNTech
ChileDepartment of Statistics and Health InformationApr. 9, 2021Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionApr. 10, 2021Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac
ColombiaMinistry of Health via Universidad de La SabanaApr. 9, 2021Pfizer/BioNTech, Sinovac
Costa RicaCosta Rican Social Security FundApr. 6, 2021Pfizer/BioNTech
Cote d’IvoireMinistry of Health and Public HygieneApr. 9, 2021Oxford/AstraZeneca
CroatiaMinistry of HealthApr. 8, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CyprusGovernment of CyprusApr. 9, 2021Pfizer/BioNTech
CzechiaMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
DenmarkStatens Serum InstitutApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
DominicaGovernment of DominicaApr. 1, 2021Oxford/AstraZeneca
Dominican RepublicMinistry of Public HealthApr. 1, 2021Oxford/AstraZeneca, Sinovac
EcuadorGovernment of Ecuador via EcuacovidApr. 6, 2021Pfizer/BioNTech
EgyptMinistry of HealthApr. 4, 2021Oxford/AstraZeneca, Sinopharm/Beijing
El SalvadorMinistry of HealthApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EnglandGovernment of the United KingdomApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthApr. 1, 2021Sinopharm/Beijing
EstoniaNational Health BoardApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniGovernment of EswatiniApr. 5, 2021Oxford/AstraZeneca
Faeroe IslandsGovernment of the Faeroe IslandsApr. 8, 2021Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 7, 2021Oxford/AstraZeneca
FinlandFinnish Institute for Health and WelfareApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GabonMinistry of HealthApr. 2, 2021Sinopharm/Beijing
GambiaMinistry of HealthApr. 6, 2021Oxford/AstraZeneca
GeorgiaGovernment of GeorgiaApr. 10, 2021Oxford/AstraZeneca
GermanyRobert Koch InstitutApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaGovernment of GhanaApr. 9, 2021Oxford/AstraZeneca
GibraltarGovernment of GibraltarApr. 10, 2021Pfizer/BioNTech
GreeceMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandMar. 1, 2021Pfizer/BioNTech
GrenadaGovernment of GrenadaMar. 24, 2021Oxford/AstraZeneca
GuatemalaMinistry of HealthApr. 9, 2021Moderna, Oxford/AstraZeneca
GuernseyGovernment of GuernseyApr. 7, 2021Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyApr. 9, 2021Sputnik V
GuyanaMinistry of HealthApr. 3, 2021Oxford/AstraZeneca
HondurasGovernment of HondurasApr. 3, 2021Moderna, Oxford/AstraZeneca
Hong KongGovernment of Hong KongApr. 10, 2021Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaMinistry of HealthApr. 10, 2021Covaxin, Oxford/AstraZeneca
IndonesiaMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Sinovac
IranGovernment of IranMar. 19, 2021Sputnik V
IraqMinistry of HealthApr. 5, 2021Oxford/AstraZeneca, Sinopharm/Beijing
IrelandHeath Service ExecutiveApr. 7, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
IsraelGovernment of IsraelApr. 10, 2021Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaGovernment of JamaicaApr. 7, 2021Oxford/AstraZeneca
JapanMinistry of Health, Labour and WelfareApr. 9, 2021Pfizer/BioNTech
JerseyGovernment of JerseyApr. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech
JordanGovernment of JordanApr. 7, 2021Pfizer/BioNTech, Sinopharm/Beijing
KazakhstanGovernment of KazakhstanMar. 18, 2021Sputnik V
KenyaMinistry of HealthApr. 7, 2021Oxford/AstraZeneca
KosovoMinistry of HealthApr. 4, 2021Oxford/AstraZeneca
KuwaitMinistry of HealthMar. 29, 2021Pfizer/BioNTech
KyrgyzstanMinistry of HealthApr. 7, 2021Sinopharm/Beijing
LaosGovernment of LaosMar. 17, 2021Sinopharm/Beijing, Sputnik V
LatviaNational Health ServiceApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LebanonGovernment of LebanonApr. 10, 2021Pfizer/BioNTech
LiechtensteinFederal Office of Public HealthApr. 7, 2021Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgApr. 8, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoApr. 10, 2021Pfizer/BioNTech, Sinopharm/Beijing
MalawiMinistry of HealthApr. 10, 2021Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaApr. 9, 2021Pfizer/BioNTech, Sinovac
MaldivesPresidency of the MaldivesApr. 10, 2021Oxford/AstraZeneca
MaliMinistry of HealthApr. 2, 2021Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaMinistry of HealthApr. 1, 2021Sinopharm/Beijing
MauritiusNational Communication Committee on COVID-19Feb. 17, 2021Oxford/AstraZeneca
MexicoSecretary of HealthApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthApr. 9, 2021Oxford/AstraZeneca
MonacoNational CouncilApr. 2, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnApr. 9, 2021Oxford/AstraZeneca
MontenegroGovernment of MontenegroApr. 10, 2021Sinopharm/Beijing, Sputnik V
MontserratGovernment of MontserratMar. 17, 2021Oxford/AstraZeneca
MoroccoMinistry of HealthApr. 10, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MozambiqueDeputy National Director of Public HealthMar. 23, 2021Sinopharm/Beijing
MyanmarMinistry of HealthFeb. 5, 2021Oxford/AstraZeneca
NamibiaMinistry of Health and Social ServicesApr. 8, 2021Sinopharm/Beijing
NepalGovernment of NepalMar. 19, 2021Oxford/AstraZeneca
NetherlandsNational Institute for Public Health and the EnvironmentApr. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New ZealandMinistry of HealthApr. 6, 2021Pfizer/BioNTech
NigeriaGovernment of NigeriaApr. 6, 2021Oxford/AstraZeneca
North MacedoniaGovernment of North MacedoniaApr. 10, 2021Pfizer/BioNTech
Northern CyprusMinistry of HealthMar. 25, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthApr. 8, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
OmanMinistry of HealthApr. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
PakistanNational Command and Operation CentreApr. 8, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
PalestineMinistry of HealthApr. 8, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PanamaMinistry of HealthApr. 10, 2021Pfizer/BioNTech
Papua New GuineaGovernment of Papua New GuineaApr. 4, 2021Oxford/AstraZeneca
ParaguayGovernment of ParaguayApr. 7, 2021Sputnik V
PeruMinistry of HealthApr. 9, 2021Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesGovernment of the PhilippinesApr. 6, 2021Oxford/AstraZeneca, Sinovac
PolandMinistry of HealthApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodApr. 10, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthApr. 10, 2021Pfizer/BioNTech
RomaniaGovernment of RomaniaApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruApr. 10, 2021EpiVacCorona, Sputnik V
RwandaMinistry of HealthMar. 25, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Saint HelenaGovernment of Saint HelenaMar. 15, 2021Oxford/AstraZeneca
Saint Kitts and NevisGovernment of Saint Kitts and NevisMar. 27, 2021Oxford/AstraZeneca
Saint LuciaMinistry of HealthApr. 10, 2021Oxford/AstraZeneca
Saint Vincent and the GrenadinesMinistry of HealthMar. 26, 2021Oxford/AstraZeneca
San MarinoSocial Security InstituteApr. 9, 2021Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeMinistry of HealthMar. 29, 2021Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
SenegalMinistry of HealthApr. 10, 2021Sinopharm/Beijing
SerbiaGovernment of SerbiaApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesExtended Programme for ImmunisationApr. 6, 2021Oxford/AstraZeneca, Sinopharm/Beijing
Sierra LeoneMinistry of Health and SanitationMar. 31, 2021Oxford/AstraZeneca
SingaporeMinistry of HealthApr. 6, 2021Moderna, Pfizer/BioNTech
SlovakiaMinistry of HealthApr. 10, 2021Pfizer/BioNTech
SloveniaNational Institute of Public HealthApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsGovernment of the Solomon IslandsMar. 31, 2021Oxford/AstraZeneca
South AfricaMinistry of HealthApr. 10, 2021Johnson&Johnson
South KoreaKorea Centers for Disease Control and PreventionApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech
SpainMinistry of HealthApr. 9, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitApr. 9, 2021Oxford/AstraZeneca
SudanFederal Ministry of HealthApr. 6, 2021Oxford/AstraZeneca
SurinameGovernment of SurinameApr. 9, 2021Oxford/AstraZeneca
SwedenPublic Health Agency of SwedenApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthApr. 7, 2021Moderna, Pfizer/BioNTech
SyriaMinistry of HealthApr. 8, 2021Sputnik V
TaiwanTaiwan Centers for Disease ControlApr. 9, 2021Oxford/AstraZeneca
ThailandGovernment of ThailandApr. 10, 2021Oxford/AstraZeneca, Sinovac
TogoGovernment of TogoMar. 24, 2021Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthApr. 8, 2021Oxford/AstraZeneca
TunisiaMinistry of HealthApr. 9, 2021Pfizer/BioNTech, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformApr. 10, 2021Pfizer/BioNTech, Sinovac
Turks and Caicos IslandsMinistry of HealthMar. 21, 2021Pfizer/BioNTech
UgandaMinistry of HealthApr. 8, 2021Oxford/AstraZeneca
UkraineMinistry of HealthApr. 10, 2021Oxford/AstraZeneca
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityApr. 10, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionApr. 10, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of HealthApr. 10, 2021Pfizer/BioNTech, Sinovac
UzbekistanGovernment of UzbekistanApr. 6, 2021Oxford/AstraZeneca
VenezuelaGovernment of VenezuelaApr. 2, 2021Sputnik V
VietnamGovernment of VietnamApr. 9, 2021Oxford/AstraZeneca
WalesGovernment of the United KingdomApr. 9, 2021Oxford/AstraZeneca, Pfizer/BioNTech
ZimbabweMinistry of HealthApr. 10, 2021Sinopharm/Beijing

Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.